Archer-Daniels-Midland Co
Change company Symbol lookup
Select an option...
ADM Archer-Daniels-Midland Co
ME 23andMe Holding Co.
UZAPF Flughafen Zuerich AG
SLVO Credit Suisse X-Links Silver Shares Covered Call ETN
ARQQ Arqit Quantum Inc
MA Mastercard Inc
BEN Franklin Resources Inc
REGN Regeneron Pharmaceuticals Inc
PSNL Personalis Inc
CORR CorEnergy Infrastructure Trust Inc
Go

Consumer Staples : Food Products | Mid Cap Value
Company profile

Archer-Daniels-Midland Company owns and operates grain elevator and transportation network to procure, store, clean, and transport agricultural raw materials, such as oilseeds, corn, wheat, milo, oats, and barley. The Company’s operations are organized into three reportable business segments: Ag Services and Oilseeds, Carbohydrate Solutions, and Nutrition. The Ag Services and Oilseeds segment includes global activities related to the origination, merchandising, transportation, and storage of agricultural raw materials. The Carbohydrate Solutions segment converts corn and wheat into products and ingredients used in the food and beverage industry, including sweeteners, corn and wheat starches, syrup, wheat flour and dextrose. The Nutrition segment engages in the manufacturing, sale, and distribution of various ingredients and solutions, including plant-based proteins, flavor systems, natural colors, emulsifiers, soluble fiber, enzymes, and other specialty food and feed ingredients.

Postmarket

Last Trade
Delayed
$71.05
0.05 (0.07%)
Bid
--
Ask
--
B/A Size
--

Market Hours

Closing Price
$71.00
Day's Change
-0.27 (-0.38%)
Bid
--
Ask
--
B/A Size
--
Day's High
72.12
Day's Low
71.00
Volume
(Above Average)
Volume:
2,567,965

10-day average volume:
2,258,674
2,567,965

ADM Further Expands Microbial Science and Technology Innovation Capabilities with Investment in Precision Fermentation Leader Acies Bio

9:25 am ET October 22, 2021 (BusinessWire) Print

ADM (NYSE: ADM), a global leader in nutrition and agricultural origination and processing, announced today that it is making a leading equity investment in Acies Bio, a Slovenia-based biotechnology company specializing in R&D and manufacturing services for developing and scaling synthetic biology and precision fermentation technologies for food, agriculture and industrial applications.

This investment will help ADM more quickly advance projects in the field of precision microbial fermentation by leveraging Acies Bio's extensive microbial capabilities and contract manufacturing services.

"Microbial technology is unlocking disruptive opportunities in sustainable agriculture, sustainable materials and fuels, and alternative proteins," said Ian Pinner, ADM chief strategy and innovation officer. "We're propelling growth opportunities by working with innovators who appreciate our unique combination of expertise, capacity and access to feedstocks. Now, by investing to become a minority owner in Acies Bio, we're opening up the door to new collaboration with an innovative, complementary business to meet the growing demand for products developed via microbial fermentation."

Founded in 2006, Acies Bio develops innovative, proprietary microbial and synthetic biology-based platforms and technologies and also offers contract R&D services in microbial strain engineering and fermentation for customers in key growth segments, including sustainable agriculture, functional foods and bio-based industrial chemicals.

"Acies Bio's core mission is to use the nearly unlimited power of microbial diversity to drive disruptive innovation and help create a more sustainable bio-based future," said Enej Kuscer, Acies Bio's co-founder and director. "This strategic partnership with ADM will allow Acies Bio to expand and accelerate the development of our platform technologies, which aim to replace synthetic chemicals and the often carbon-intensive production currently used in food and agriculture with microbial, bio-based products."

"This investment from ADM will also allow Acies Bio to expand our infrastructure and increase the high-throughput capabilities of our SmartRoute platform, which will allow faster development of new technologies and products," said Stefan Fujs, Acies Bio's co-founder and director. "This will speed-up the internal pipeline and also help us deliver more quality services to our partners and collaborators."

ADM's investment in Acies Bio is being made through ADM Ventures, the company's corporate venture capital arm. ADM Ventures invests in cutting-edge start-ups with disruptive technologies across three key areas: human nutrition, animal nutrition and sustainability. ADM Ventures also seeks startups that utilize ADM's assets and feedstocks to produce sustainable materials, in addition to technologies that enhance the effectiveness or efficiency of ADM's operations.

About Acies Bio

Acies Bio is a leading European microbial biotechnology company that develops new bioproducts and sustainable production processes for diverse industrial sectors, including pharma, food/feed, agricultural, and industrial biotechnology. With an emphasis on sustainability and using Acies Bio's unique SmartRoute microbial platform, including synthetic biology and strain engineering, high-throughput screening, precision bioprocess and downstream development, the company has successfully developed and scaled numerous innovative products and precision fermentation technologies with industrial partners worldwide. Learn more at www.aciesbio.com.

About ADM

At ADM, we unlock the power of nature to provide access to nutrition worldwide. With industry-advancing innovations, a complete portfolio of ingredients and solutions to meet any taste, and a commitment to sustainability, we give customers an edge in solving the nutritional challenges of today and tomorrow. We're a global leader in human and animal nutrition and the world's premier agricultural origination and processing company. Our breadth, depth, insights, facilities and logistical expertise give us unparalleled capabilities to meet needs for food, beverages, health and wellness, and more. From the seed of the idea to the outcome of the solution, we enrich the quality of life the world over. Learn more at www.adm.com.

Source: Corporate Release

View source version on businesswire.com: https://www.businesswire.com/news/home/20211022005283/en/

SOURCE: ADM

ADM Media Relations 
Jackie Anderson 
media@adm.com 
312-634-8484 

AciesBio Contact 
Matevz Kmet
matevz.kmet@aciesbio.com 
+386 590 75995
comtex tracking

COMTEX_395667570/1006/2021-10-22T09:25:00

Earnings Calendar and Events Data provided by |Terms of Use| © 2022 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

Information and news provided by ,, , Computrade Systems, Inc., ,, and

Copyright © 2022. All rights reserved.